PRZOOM - /newswire/ -
Palo Alto, CA, United States, 2007/05/07 - The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Healthcare 2007 Quarterly Analyst Briefing Presentation on the drug discovery technologies market to be held on Thursday, May 10, 2007 at 1:00 pm ET/12:00 pm CT.
The markets for general life sciences tools and drug discovery technologies have remained flat with little or no growth since 2003. However, a selection of innovative and enabling platforms continues to incite optimism among market participants. Revenues generated from the sales of certain technologies, such as RNAi, qRT-PCR, DNA microarray, proteomics array, and microfluidics/ lab-on-a-chip, are expected to sustain many market participants' high single-digit and low double-digit growth between 2007 and 2012.
Highlights of the briefing will include an examination of market trends and forecasts relating to coming applications, growth opportunities, and industry obstacles for high-growth life sciences tools and drug discovery technologies.
This briefing will benefit life sciences research tool and drug discovery technology developers and distributors, contract research services providers, life sciences consumables and informatics suppliers, and companies that participate in the broader industries of diagnostics and biotechnology.
"Life sciences research tool and drug discovery technology market participants are continually evaluating multiple technologies for possible integration into their product portfolios," notes Frost & Sullivan Industry Analyst Jonathan Witonsky. "While the bulk of revenues are associated with the sales of traditional or commoditized technologies, a considerable amount of growth is likely to be driven by the adoption of best-in-market platforms."
To participate, please email Melina Trevino at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.